These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6799391)

  • 1. Chemical typing of human kappa light chain subgroups expressed by human hybrid myelomas.
    Galfrè G; Milstein C
    Immunology; 1982 Jan; 45(1):125-8. PubMed ID: 6799391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Allelic exclusion in hybridomas. I. Isolation and properties of a hybrid clone producing two allelic variants of light chain immunoglobulins in the rat].
    Cherepakhin VV; Petrosian MN; Ibragimov AR; Bogacheva GT; Trakht IN
    Mol Biol (Mosk); 1984; 18(2):474-80. PubMed ID: 6425644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
    Pickering JW; Gelder FB
    J Immunol; 1982 Jul; 129(1):406-12. PubMed ID: 6806365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The surface expression of a tumor-associated antigen on human kappa myeloma cells.
    Boux HA; Raison RL; Walker KZ; Musgrove E; Basten A
    Eur J Immunol; 1984 Mar; 14(3):216-22. PubMed ID: 6423392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of human light chain synthesis by human-mouse myeloma hybrids.
    Cieplinski W; Wardwell J; Schwink AM
    Cancer Biochem Biophys; 1983 Dec; 7(1):1-10. PubMed ID: 6421474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid specific amplification of rat antibody cDNA from nine hybridomas in the presence of myeloma light chains.
    Brady JL; Corbett AJ; McKenzie BS; Lew AM
    J Immunol Methods; 2006 Aug; 315(1-2):61-7. PubMed ID: 16901500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal competition and stability of hybrid myelomas of mouse and rat origin.
    Galfré G; Butcher GW; Howard JC; Wide CD; Milstein C
    Transplant Proc; 1980 Sep; 12(3):371-5. PubMed ID: 6784297
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitation of light chain synthesis in myeloma x spleen cell hybrids and identification of myeloma chain loss variants using radioimmunoassay.
    Springer TA
    J Immunol Methods; 1980; 37(2):139-52. PubMed ID: 6777428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic properties of human IgG Kappa and IgG lambda myeloma plasma cells.
    Hagner G
    Exp Hematol; 1983 Mar; 11(3):219-25. PubMed ID: 6403367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. kappa-Chain restriction in anti-galactan antibodies.
    Pawlita M; Potter M; Rudikoff S
    J Immunol; 1982 Aug; 129(2):615-8. PubMed ID: 6806376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody repertoires of four- and five-feature translocus mice carrying human immunoglobulin heavy chain and kappa and lambda light chain yeast artificial chromosomes.
    Nicholson IC; Zou X; Popov AV; Cook GP; Corps EM; Humphries S; Ayling C; Goyenechea B; Xian J; Taussig MJ; Neuberger MS; Brüggemann M
    J Immunol; 1999 Dec; 163(12):6898-906. PubMed ID: 10586092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines.
    Köhler G; Howe SC; Milstein C
    Eur J Immunol; 1976 Apr; 6(4):292-5. PubMed ID: 825374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the serum of a patient affected by myeloma with diffuse muscular hypertrophy on the growth of human muscle cells in vitro].
    Delaporte C; Drouin F; Ract AR; Varet B; Fardeau M
    Rev Neurol (Paris); 1985; 141(2):109-19. PubMed ID: 3923591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tumor-associated antigen specific for human kappa myeloma cells.
    Boux HA; Raison RL; Walker KZ; Hayden GE; Basten A
    J Exp Med; 1983 Nov; 158(5):1769-74. PubMed ID: 6195295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of the GM 4672 human lymphoblastoid cell line and analysis of its use as a fusion partner in the generation of human-human hybridoma autoantibodies.
    Rioux JD; Rauch J; Zdarsky E; Newkirk MM
    Hum Antibodies Hybridomas; 1993 Jul; 4(3):107-14. PubMed ID: 7689347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing murine monoclonal antibodies to human IL-5 isolated from hybridomas and a filamentous phage Fab display library.
    Ames RS; Tornetta MA; McMillan LJ; Kaiser KF; Holmes SD; Appelbaum E; Cusimano DM; Theisen TW; Gross MS; Jones CS
    J Immunol; 1995 Jun; 154(12):6355-64. PubMed ID: 7759873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro interaction of LDL, anti-lipoprotein IgA and human fibroblasts.
    Baudet MF; Dachet C; Beaumont JL
    Biomedicine; 1978 Oct; 29(6):217-20. PubMed ID: 216434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of human immunoglobulins by mouse myeloma x Daudi somatic cell hybrids.
    Erikson J; Croce CM
    Eur J Immunol; 1982 Aug; 12(8):697-701. PubMed ID: 6754388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of loss of human kappa light chain expression in mouse-human heterohybridomas.
    Uchiyama K; Saito H; Tokuhisa T; Imai K; Taniguchi M
    Hybridoma; 1987 Dec; 6(6):645-54. PubMed ID: 3125100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell tolerance to kappa light chain (L kappa): identification of a naturally processed self-C kappa-peptidic region by specific CD4+ T cell hybridomas obtained in L kappa-deficient mice.
    Faure M; Sanchez P; Cazenave PA; Rueff-Juy D
    Cell Immunol; 1997 Aug; 180(1):84-92. PubMed ID: 9316642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.